http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18021947

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1045
issn 1532-1827
0007-0920
issueIdentifier 8
pageRange 1040-1045
publicationName British Journal of Cancer
startingPage 1040
bibliographicCitation Gamucci T, D'Ottavio AM, Magnolfi E, Barduagni M, Vaccaro A, Sperduti I, Moscetti L, Belli F, Meliffi L. Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. British Journal of Cancer. 2007 Oct 16;97(8):1040–5. doi: 10.1038/sj.bjc.6603982.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5a841ab02e1dc3a70dfe7c81ff80a6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a14d62e1ddd3cece007b537604711ae0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf6562c6414db9d975ab7f9b1c5d3554
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4123ef939175147f713b17f51873b69c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc747937a1ed110fb8c90709c3f8786f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_398f820632de8d30420d7dd7356b7b08
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6fde923618d996084c4cf63d7f70b0e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d51c3e1c1b7e6b764b0df06cef6e691
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d31590efcef2b3ca571f0e186226f522
date 2007-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/17940499
https://pubmed.ncbi.nlm.nih.gov/PMC2360453
https://doi.org/10.1038/sj.bjc.6603982
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
https://portal.issn.org/resource/ISSN/0007-0920
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
discusses http://id.nlm.nih.gov/mesh/M0023488
http://id.nlm.nih.gov/mesh/M0184558
http://id.nlm.nih.gov/mesh/M0443608
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ed75134b36b0e173fb44798462e4e66
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d7fe60f25abdf582afc7cdca238bde8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11499
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129138006
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129307185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129046631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127638306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536

Total number of triples: 54.